The OpenAlex profile matched to Jin Zhu (ORCID 0000-0002-6116-7774) reports 473 works, 27,074 citations, and an h-index of 90 β a senior, highly productive profile by any standard; this places the author in roughly the top tier of active researchers, though well below the co-located mega-profiles (e.g., Zhong Lin Wang, h = 325) that a naive name query also surfaces.
The strongest supplied papers combine novel methods with orthogonal validation: the CTCF work built a 276,765-sequence binding landscape plus a CNN predicting affinity at Spearman Ο β 0.90 (vs. PWM Ο = 0.33) and validated a SLE-associated variant by prime editing in Raji cells with 4C-seq, ChIP-seq, and qRT-PCR evidence of BLK insulation loss . The CellChem framework achieved AUROC 0.864 (random) / 0.757 (scaffold-split) for CPI prediction and experimentally validated PLK1 inhibitors (6 of 9 assayed with IC50 < 1 ΞΌM) and GPR6 inverse agonists . The SWISS rice-editing platform demonstrated simultaneous CBE, ABE, and indel editing with whole-genome-sequenced off-target assessment (12 lines vs. 10 controls) .
Several clinical/biomedical records show thin statistics: the venetoclax-resistance analysis rests on N = 9 retrospective patients with no external validation , and the CAR-T biomarker study (N = 44, single center, AUC 0.816 for response prediction) lacks an independent cohort . The arousal-connectome preprint honestly reports modest cross-dataset correlations (r = 0.08β0.15) and single-measure autonomic reliance . The image-encryption conference paper is the clear low point (score 4/10): single test image, garbled parameters, poor reproducibility .
The supplied papers span cellular neuroscience, chromatin biology, CRISPR crop engineering, reproductive mechanobiology, traffic-flow physics, polymer chemistry, nanomedicine, and helminth-free fields no single scientist plausibly covers. This is almost certainly multiple distinct researchers named Jin Zhu β OpenAlex itself lists at least two separate 'Jin Zhu' entities (h-indices 90 and 82 among others), and name-based author reviews conflate disambiguation errors, citation-credit inflation, and heterogeneity. Per-field claims above are valid; a unified single-author verdict is not.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.